Related Experiment Video
Updated: Dec 3, 2025

12:23
In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
Published on: September 7, 2022
1.9K
Isolation of extracellular vesicles with multivalent aptamers
1The Pq Laboratory of Micro/Nano BiomeDx, Department of Biomedical Engineering, Binghamton University-SUNY, Binghamton, NY 13902, USA. ywan@binghamton.edu.
The Analyst
|October 27, 2020
Summary
Researchers developed a novel multivalent aptamer method for efficiently isolating extracellular vesicles (EVs). This technique rapidly enriches tumor-derived EVs for improved cancer liquid biopsy and leukemia studies.
Area of Science:
- Biotechnology
- Molecular Biology
- Nanotechnology
Background:
- Extracellular vesicles (EVs) are crucial intercellular communicators involved in disease pathophysiology.
- EV contents are utilized in cancer diagnosis and treatment monitoring, highlighting the need for effective isolation methods.
- Current EV isolation techniques face challenges like low specificity and lengthy procedures, hindering clinical translation.
Purpose of the Study:
- To develop an efficient and specific method for isolating tumor-derived EVs from body fluids.
- To overcome the limitations of existing EV isolation techniques for improved cancer liquid biopsy.
- To facilitate EV-centered research in diseases like acute lymphoblastic leukemia.
Main Methods:
- Utilized a multivalent, long single-stranded aptamer (MA) for EV enrichment and retrieval.
- Anchored biotin-labeled MAs with bound EVs onto streptavidin-coated microspheres.
- Retrieved EVs via DNA aptamer digestion using DNase.
Main Results:
- Isolated approximately 45% of spiked EVs within 40 minutes.
- Achieved 84.7% depletion of albumin contamination.
- Successfully retrieved 93.1% of isolated EVs using DNase in 10 minutes for downstream analysis.
Conclusions:
- The multivalent aptamer method offers efficient and specific isolation of EVs.
- This simple approach can significantly advance EV-centered studies, particularly for acute lymphoblastic leukemia.
- The method shows promise for large-scale clinical implementation of EV-based liquid biopsies.

